Geode Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-330,898
| Closed | -$46.3M | – | 4197 |
|
|
2018
Q4 | $46.3M | Buy |
330,898
+15,413
| +5% | +$2.16M | 0.01% | 770 |
|
|
2018
Q3 | $53.9M | Buy |
315,485
+65,844
| +26% | +$11.2M | 0.02% | 765 |
|
|
2018
Q2 | $43.3M | Buy |
249,641
+35,529
| +17% | +$6.16M | 0.01% | 845 |
|
|
2018
Q1 | $24.7M | Buy |
214,112
+9,030
| +4% | +$1.04M | 0.01% | 1110 |
|
|
2017
Q4 | $17.3M | Sell |
205,082
-12,144
| -6% | -$1.02M | 0.01% | 1364 |
|
|
2017
Q3 | $20M | Buy |
217,226
+37,372
| +21% | +$3.44M | 0.01% | 1237 |
|
|
2017
Q2 | $14.4M | Buy |
179,854
+43,578
| +32% | +$3.49M | 0.01% | 1436 |
|
|
2017
Q1 | $5.73M | Buy |
136,276
+44,193
| +48% | +$1.86M | ﹤0.01% | 2009 |
|
|
2016
Q4 | $2.96M | Sell |
92,083
-8,697
| -9% | -$279K | ﹤0.01% | 2404 |
|
|
2016
Q3 | $2.64M | Buy |
100,780
+3,487
| +4% | +$91.3K | ﹤0.01% | 2389 |
|
|
2016
Q2 | $2.26M | Buy |
97,293
+40,225
| +70% | +$932K | ﹤0.01% | 2401 |
|
|
2016
Q1 | $1.56K | Buy |
57,068
+2,126
| +4% | +$58 | ﹤0.01% | 2609 |
|
|
2015
Q4 | $1.56M | Buy |
54,942
+10,700
| +24% | +$304K | ﹤0.01% | 2627 |
|
|
2015
Q3 | $773K | Buy |
44,242
+10,582
| +31% | +$185K | ﹤0.01% | 3022 |
|
|
2015
Q2 | $606K | Buy |
33,660
+4,868
| +17% | +$87.6K | ﹤0.01% | 3122 |
|
|
2015
Q1 | $358K | Buy |
28,792
+997
| +4% | +$12.4K | ﹤0.01% | 3334 |
|
|
2014
Q4 | $326K | Buy |
+27,795
| New | +$326K | ﹤0.01% | 3381 |
|